Extended somatostatin treatment of a patient with bleeding ulcer

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
P MattesR Scheck

Abstract

The results of a 67 hour cyclic somatostatin continuous infusion in a patient with a bleeding ulcer are reported. The subject was a 65 year old male with very heavy gastrointestinal bleeding on the 9th postoperative day following a high BI-resection. Endoscopy revealed the bleeding to be caused by two residual ulcers in the area of the anastomosis. Somatostatin treatment led to an immediate cessation of the bleeding after 1 hour. Gastric secretion as well as gastrin, insulin and growth hormone levels were significantly inhibited by somatostatin. Endoscopy at the end of the treatment period showed two ulcers in the process of healing. The raised blood glucose levels caused by somatostatin were easily controlled with max. 14 IU cristalline insulin daily. Except for dryness in the mouth, no adverse side effects were apparent. There was no evidence from laboratory investigations of hemostatic defects or bleeding tendency in the patient.

Citations

Jul 15, 1977·European Journal of Pharmacology·U SchwedesS Szabo
Jan 1, 1986·Peptides·G GhirlandaA V Greco
Mar 29, 1979·The New England Journal of Medicine·S Raptis, C Zoupas
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S J KonturekA V Schally
Oct 15, 1976·Klinische Wochenschrift·H RascheE F Pfeiffer
Nov 12, 1976·Langenbecks Archiv für Chirurgie·P MattesS Raptis
Feb 12, 2008·Plant Cell Reports·Tae-Geum KimMoon-Sik Yang
Nov 1, 1977·The American Journal of Digestive Diseases·S J KonturekZ Wierzbicki
Jan 1, 1982·Acta Medica Scandinavica·U AdamsonA Wajngot
Sep 1, 1978·Metabolism: Clinical and Experimental·W Creutzfeldt, R Arnold

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.